Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia

Abstract The tryptophan (TRP)-kynurenine (KYN) pathway is involved in the pathogenesis of schizophrenia. This study aimed to investigate the levels of TRP-KYN metabolites in serum and urine of patients with first-episode schizophrenia (FES) and their association with clinical manifestations. This st...

Full description

Saved in:
Bibliographic Details
Main Authors: Mian Li, Yue Wu, Yan Xu, Xin Huang, Kerun Gao, Nannan Hu, Shuangyue Zhu, Chengpeng Wang, Sugai Liang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86390-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594726755237888
author Mian Li
Yue Wu
Yan Xu
Xin Huang
Kerun Gao
Nannan Hu
Shuangyue Zhu
Chengpeng Wang
Sugai Liang
author_facet Mian Li
Yue Wu
Yan Xu
Xin Huang
Kerun Gao
Nannan Hu
Shuangyue Zhu
Chengpeng Wang
Sugai Liang
author_sort Mian Li
collection DOAJ
description Abstract The tryptophan (TRP)-kynurenine (KYN) pathway is involved in the pathogenesis of schizophrenia. This study aimed to investigate the levels of TRP-KYN metabolites in serum and urine of patients with first-episode schizophrenia (FES) and their association with clinical manifestations. This study included 38 drug-naive patients with FES and 43 healthy controls (HCs). Clinical symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS). Levels of TRP-KYN metabolites in serum and urine were quantified. Patients with FES showed significantly higher serum quinolinic acid/kynurenic acid (QUIN/KYNA) ratio and urine KYN/TRP ratio compared to HCs, while neuroprotective metabolites, including serum KYNA, xanthurenic acid (XA), and urine picolinic acid (PIC) levels, were significantly reduced, along with a decreased urine PIC/QUIN ratio (p < 0.05). The urine KYNA/KYN ratio was negatively correlated with PANSS general psychopathology scores (r = -0.35, p = 0.04) and with PANSS total scores (r = -0.35, p = 0.046). Patients with FES exhibited dysregulation of the peripheral TRP-KYN pathway, characterized by an increased neurotoxic-to-neuroprotective QUIN/KYNA ratio and reduced levels of neuroprotective metabolites. This shift towards increased neurotoxic product generation suggests that the dysregulation of the TRP-KYN pathway could play a role in the pathophysiology of schizophrenia.
format Article
id doaj-art-e41581babb554a72a138dc9b3203f5bf
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e41581babb554a72a138dc9b3203f5bf2025-01-19T12:23:43ZengNature PortfolioScientific Reports2045-23222025-01-011511810.1038/s41598-025-86390-4Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophreniaMian Li0Yue Wu1Yan Xu2Xin Huang3Kerun Gao4Nannan Hu5Shuangyue Zhu6Chengpeng Wang7Sugai Liang8Affiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAffiliated Mental Health Centre & Hangzhou Seventh People’s Hospital, Zhejiang University School of MedicineAbstract The tryptophan (TRP)-kynurenine (KYN) pathway is involved in the pathogenesis of schizophrenia. This study aimed to investigate the levels of TRP-KYN metabolites in serum and urine of patients with first-episode schizophrenia (FES) and their association with clinical manifestations. This study included 38 drug-naive patients with FES and 43 healthy controls (HCs). Clinical symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS). Levels of TRP-KYN metabolites in serum and urine were quantified. Patients with FES showed significantly higher serum quinolinic acid/kynurenic acid (QUIN/KYNA) ratio and urine KYN/TRP ratio compared to HCs, while neuroprotective metabolites, including serum KYNA, xanthurenic acid (XA), and urine picolinic acid (PIC) levels, were significantly reduced, along with a decreased urine PIC/QUIN ratio (p < 0.05). The urine KYNA/KYN ratio was negatively correlated with PANSS general psychopathology scores (r = -0.35, p = 0.04) and with PANSS total scores (r = -0.35, p = 0.046). Patients with FES exhibited dysregulation of the peripheral TRP-KYN pathway, characterized by an increased neurotoxic-to-neuroprotective QUIN/KYNA ratio and reduced levels of neuroprotective metabolites. This shift towards increased neurotoxic product generation suggests that the dysregulation of the TRP-KYN pathway could play a role in the pathophysiology of schizophrenia.https://doi.org/10.1038/s41598-025-86390-4SchizophreniaTryptophan-kynurenine pathwayPeripheral metabolitesNeurotoxicityNeuroprotection
spellingShingle Mian Li
Yue Wu
Yan Xu
Xin Huang
Kerun Gao
Nannan Hu
Shuangyue Zhu
Chengpeng Wang
Sugai Liang
Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
Scientific Reports
Schizophrenia
Tryptophan-kynurenine pathway
Peripheral metabolites
Neurotoxicity
Neuroprotection
title Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
title_full Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
title_fullStr Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
title_full_unstemmed Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
title_short Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
title_sort peripheral tryptophan kynurenine pathway dysfunction in first episode schizophrenia
topic Schizophrenia
Tryptophan-kynurenine pathway
Peripheral metabolites
Neurotoxicity
Neuroprotection
url https://doi.org/10.1038/s41598-025-86390-4
work_keys_str_mv AT mianli peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT yuewu peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT yanxu peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT xinhuang peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT kerungao peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT nannanhu peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT shuangyuezhu peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT chengpengwang peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia
AT sugailiang peripheraltryptophankynureninepathwaydysfunctioninfirstepisodeschizophrenia